The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Astellas Oncology; Bristol-Myers Squibb; Ipsen; Janssen
A phase II multicenter biomarker trial to study the predictive value of TMPRSS2-ERG before enzalutamide treatment in chemo-naïve metastatic castration-resistant prostate cancer.
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Lexicon; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Roche
Consulting or Advisory Role - Ipsen; MSD; Pfizer
Research Funding - AstraZeneca (Inst); Ipsen (Inst); MTEM/Threshold (Inst); Pfizer (Inst); Roche
 
Maria Piedad Fernandez Perez
No Relationships to Disclose
 
Daniel Wetterskog
No Relationships to Disclose
 
Albert Font Pous
Consulting or Advisory Role - Janssen; Roche; Sanofi Pasteur
Research Funding - Astellas Oncology; AstraZeneca; Pierre Fabre
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi
Speakers' Bureau - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche Pharma AG
 
Aránzazu Gonzalez del Alba
No Relationships to Disclose
 
Begona Mellado
No Relationships to Disclose
 
Ovidio Fernandez Calvo
Honoraria - Astellas Medivation; Ipsen; Janssen Biotech; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Maria Jose Mendez-Vidal
No Relationships to Disclose
 
Miguel Ángel Climent
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Janssen-Cilag; Merck; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche
 
Ignacio Duran
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche/Genentech
 
Enrique Gallardo Diaz
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; EUSA Pharma; Ipsen; Janssen Oncology; Pfizer; Roche; Rovi; Sanofi; Shenzen Techdow Pharma
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Ipsen; Janssen Oncology; LEO Pharma; Menarini; Novartis; Novartis; Pfizer; Roche; Rovi; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Janssen; Pfizer; Pierre Fabre; Roche
 
Angel Rodriguez Sanchez
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche; Sanofi
 
Carmen Santander
No Relationships to Disclose
 
M Isabel Sáez
No Relationships to Disclose
 
Javier Puente
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Clovis Oncology; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Speakers' Bureau - Celgene; Kiowa; Lilly; Novartis; Pierre Fabre
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag
Consulting or Advisory Role - Bayer; Bayer (I); Janssen; Janssen (I)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche
 
Daniel E. Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Bayer; ESSA; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Enrique González-Billalabeitia
No Relationships to Disclose